Jazz Pharmaceuticals plc Stock
Jazz Pharmaceuticals plc Stock
Jazz Pharmaceuticals plc gained 0.210% compared to yesterday.
The stock is an absolute favorite of our community with 38 Buy predictions and no Sell predictions.
As a result the target price of 172 € shows a positive potential of 21.38% compared to the current price of 141.7 € for Jazz Pharmaceuticals plc.
Pros and Cons of Jazz Pharmaceuticals plc in the next few years
Pros
?
B****
?
G***** c******* t* c**********
?
W********* I********* f** t** n*** y****
Cons
?
C******** o* t** e**********
?
S********** s********
?
M***** P*******
Tell us your opinion to access the 'Wisdom of the Crowds'
Performance of Jazz Pharmaceuticals plc vs. its peers
| Security | Change(%) | 1w | 1m | 1y | YTD | 3y | 5y |
|---|---|---|---|---|---|---|---|
| Jazz Pharmaceuticals plc | 0.210% | 1.796% | -3.965% | 10.617% | -1.870% | 2.547% | 3.431% |
| Repligen Corp. | -0.480% | -4.158% | -17.531% | -17.235% | -18.175% | -35.122% | -35.470% |
| Opko Health Inc. | 3.100% | -0.549% | -4.444% | -31.806% | -6.898% | -2.778% | -78.402% |
| Amicus Therapeutics Inc. | 0.000% | 0.840% | -1.639% | 29.730% | 0.000% | 1.146% | 21.212% |
Comments
Jazz Pharmaceuticals (NASDAQ:JAZZ) had its "buy" rating reaffirmed by analysts at TD Cowen.
Show more
Ratings data for JAZZ provided by MarketBeat
Jazz Pharmaceuticals (NASDAQ:JAZZ) had its price target raised by analysts at Truist Financial Corporation from $220.00 to $230.00. They now have a "buy" rating on the stock.
Show more
Ratings data for JAZZ provided by MarketBeat
Jazz Pharmaceuticals (NASDAQ:JAZZ) had its price target raised by analysts at Needham & Company LLC from $210.00 to $235.00. They now have a "buy" rating on the stock.
Show more
Ratings data for JAZZ provided by MarketBeat